source
- Estuary Biotherapeutics raises $93 million Series A to develop gene therapies for ADPKDEstuary Biotherapeutics, a California gene‑therapy startup backed by Biogen, announced a $93 million Series A financing led by RA Capital. The capital will support development of two genetic medic…
- FDA issues warning letters to drug makers and a lab over CGMP and GLP violationsFDA sent warning letters to several drug manufacturers for not meeting current good manufacturing practice (CGMP) requirements. The letters point to issues such as ensuring final product sterility…